Status:
COMPLETED
Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
CancerCare Manitoba
Celgene
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective is to explore the impact of early palliative care on quality of life in patients with advanced pancreatic cancer. The secondary objectives are to explore the impact of early pall...
Detailed Description
This is a prospective case-crossover study of patients with advanced pancreatic cancer (APC) at CancerCare Manitoba (CCMB) with early palliative care (PALC) plus standard oncologic care. The primary ...
Eligibility Criteria
Inclusion
- age \>18
- newly diagnosed advanced pancreatic cancer (APC)
- English speaking or willing to be seen with a medical interpreter
- willing and able to complete quality of life (QoL) questionnaires
Exclusion
- age \<18
- receiving cycle 2 of chemotherapy
Key Trial Info
Start Date :
October 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03837132
Start Date
October 15 2018
End Date
June 30 2021
Last Update
February 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria General Hospital Buhler Cancer Centre
Winnipeg, Manitoba, Canada, R3T 2E8